Mycotopia Therapies Performance

TPIADelisted Stock  USD 0.02  0  14.29%   
The company secures a Beta (Market Risk) of -6.24, which conveys a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Mycotopia Therapies are expected to decrease by larger amounts. On the other hand, during market turmoil, Mycotopia Therapies is expected to outperform it. Mycotopia Therapies right now secures a risk of 0.0%. Please verify Mycotopia Therapies standard deviation, value at risk, kurtosis, as well as the relationship between the sortino ratio and semi variance , to decide if Mycotopia Therapies will be following its current price movements.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Mycotopia Therapies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong forward indicators, Mycotopia Therapies is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors. ...more
Begin Period Cash Flow57.4 K
Total Cashflows From Investing Activities-2746.00
  

Mycotopia Therapies Relative Risk vs. Return Landscape

If you would invest  1.60  in Mycotopia Therapies on November 11, 2025 and sell it today you would earn a total of  0.00  from holding Mycotopia Therapies or generate 0.0% return on investment over 90 days. Mycotopia Therapies is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than Mycotopia, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  

Mycotopia Therapies Target Price Odds to finish over Current Price

The tendency of Mycotopia Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 0.02 90 days 0.02 
about 83.56
Based on a normal probability distribution, the odds of Mycotopia Therapies to move above the current price in 90 days from now is about 83.56 (This Mycotopia Therapies probability density function shows the probability of Mycotopia Pink Sheet to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Mycotopia Therapies has a beta of -6.24. This usually implies as returns on its benchmark rise, returns on holding Mycotopia Therapies are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Mycotopia Therapies is expected to outperform its benchmark. In addition to that Mycotopia Therapies has an alpha of 5.5946, implying that it can generate a 5.59 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Mycotopia Therapies Price Density   
       Price  

Predictive Modules for Mycotopia Therapies

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Mycotopia Therapies. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.010.020.02
Details
Intrinsic
Valuation
LowRealHigh
0.010.020.02
Details

Mycotopia Therapies Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Mycotopia Therapies is not an exception. The market had few large corrections towards the Mycotopia Therapies' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Mycotopia Therapies, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Mycotopia Therapies within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
5.59
β
Beta against Dow Jones-6.24
σ
Overall volatility
0.03
Ir
Information ratio 0.13

Mycotopia Therapies Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Mycotopia Therapies for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Mycotopia Therapies can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Mycotopia Therapies is not yet fully synchronised with the market data
Mycotopia Therapies has some characteristics of a very speculative penny stock
Mycotopia Therapies has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (2.82 M) with profit before overhead, payroll, taxes, and interest of 0.
Mycotopia Therapies currently holds about 783.38 K in cash with (235.48 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 75.0% of the company outstanding shares are owned by corporate insiders

Mycotopia Therapies Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Mycotopia Pink Sheet often depends not only on the future outlook of the current and potential Mycotopia Therapies' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Mycotopia Therapies' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding12.7 M
Cash And Short Term Investments1.3 M

Mycotopia Therapies Fundamentals Growth

Mycotopia Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Mycotopia Therapies, and Mycotopia Therapies fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Mycotopia Pink Sheet performance.

About Mycotopia Therapies Performance

By analyzing Mycotopia Therapies' fundamental ratios, stakeholders can gain valuable insights into Mycotopia Therapies' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Mycotopia Therapies has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Mycotopia Therapies has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Mycotopia Therapies, Inc. focuses on psychedelics for the treatment of mental health issues. It provides psychedelic therapies for the treatment of post-traumatic stress disorder, severe anxiety, depression, palliative care, and serotonin syndrome. Mycotopia Therapies operates under Medical Care Facilities classification in the United States and is traded on OTC Exchange. It employs 1 people.

Things to note about Mycotopia Therapies performance evaluation

Checking the ongoing alerts about Mycotopia Therapies for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Mycotopia Therapies help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Mycotopia Therapies is not yet fully synchronised with the market data
Mycotopia Therapies has some characteristics of a very speculative penny stock
Mycotopia Therapies has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (2.82 M) with profit before overhead, payroll, taxes, and interest of 0.
Mycotopia Therapies currently holds about 783.38 K in cash with (235.48 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 75.0% of the company outstanding shares are owned by corporate insiders
Evaluating Mycotopia Therapies' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Mycotopia Therapies' pink sheet performance include:
  • Analyzing Mycotopia Therapies' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Mycotopia Therapies' stock is overvalued or undervalued compared to its peers.
  • Examining Mycotopia Therapies' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Mycotopia Therapies' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Mycotopia Therapies' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Mycotopia Therapies' pink sheet. These opinions can provide insight into Mycotopia Therapies' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Mycotopia Therapies' pink sheet performance is not an exact science, and many factors can impact Mycotopia Therapies' pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Consideration for investing in Mycotopia Pink Sheet

If you are still planning to invest in Mycotopia Therapies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Mycotopia Therapies' history and understand the potential risks before investing.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Commodity Directory
Find actively traded commodities issued by global exchanges
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments